ERC launched today

The first day in the life of the European funding agency for basic research is marked by optimism, assuaged concerns.

Written byAndrew Scott
| 3 min read

Register for free to listen to this article
Listen with Speechify
0:00
3:00
Share

After years of campaigning and controversy, the European Research Council (ERC) was formally launched at a conference in Berlin today (February 27). The event, creating the first pan-European funding agency that can award grants for basic research based solely on peer review, was met with seemingly widespread enthusiasm from the life sciences community.

Scientists seeking European Commission (EC) funding have generally had to negotiate application processes which many view as too political, rather than science-based -- constrained by such details as which of the Commission's priorities each proposal can be made to fit. Different member states want to see fair return to their own countries for the money they each contribute, and EC funding has traditionally been focused on applied and industrial projects. The ERC, in contrast, pledges to prioritize basic research, and award grants based solely on projects' scientific merits, not politics.

"The most important added value of a ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here

Meet the Author

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies